India's paradox: The largest drug exporter and the most isolationist drug industry

Shutterstock.com

Article Highlights

  • Dangerous or not, India’s pharmaceutical industry continues to grow because of price.

    Tweet This

  • India’s main problem now is that nationalism has replaced health protection as the guiding principle of drug regulation.

    Tweet This

  • Enforcement on adulterated drugs cannot be different in #India just because good manufacturing practices are so laxly interpreted there.

    Tweet This

The reach of the Indian pharmaceutical industry is enormous. India supplies a large and increasing amount of the generic drugs sold globally, and the country is home to over 150 drug manufacturing facilities approved by the US Food and Drug Administration1—including many run by multinational players. The value of pharmaceutical exports from India to the United States rose nearly 32 percent in 2012, to $4.2 billion.2 India supplies nearly 40 percent of generic drugs and over-the-counter products as well as 10 percent of finished dosages used in the US.3 Some of these products are very substantial: Ranbaxy, one of India’s largest pharmaceutical companies, won the right to make the only generic version of Lipitor for sale to Americans when it was the world’s best selling drug with peak annual sales of over $12 billion.4 India is one of the largest suppliers for the Internet market in western countries and is the dominant provider in most emerging markets, too.

India's paradox: The largest drug exporter and the most isolationist drug industry by American Enterprise Institute

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate
  • Roger Bate is an economist who researches international health policy, with a particular focus on tropical disease and substandard and counterfeit medicines. He also writes on general development policy in Asia and Africa. He writes regularly for AEI's Health Policy Outlook.
  • Phone: 202-828-6029
    Email: rbate@aei.org
  • Assistant Info

    Name: Katherine Earle
    Phone: (202) 862-5872
    Email: katherine.earle@aei.org

What's new on AEI

image The money in banking: Comparing salaries of bank and bank regulatory employees
image What Obama should say about China in Japan
image A key to college success: Involved dads
image China takes the fight to space
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Event Registration is Closed
Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.